in th rat. Am. J. Physiol. 229(5) : 1438-l 447. 1975.-Feeding was induced with lateral intracerebroventricular (ICV) injections of 2-deoxy-D-glucose (2-DG), a glucose analogue causing glucoprivation.
Feeding increased rapidly by an average of 2.6 g following ICV 2-DG (2.9 or 5.8 mg per rat), but did not increase after ICV n-glucose or sucrose. At the same doses, 2-DG did not increase feeding when given peripherally.
Core temperature dropped in a dose-dependent manner with doses of 2-DG sufficient to induce feeding after peripheral administration, but did not occur with ICV injections. The 2-DG (0.006-l .219 M) did not stimulate feeding when infused bilaterally into the lateral hypothalamus, the preoptic area, or the anterior lateral hypothalamus.
Nor did it produce feeding when injected into the ventromedial hypothalamus at the same sites and in the same rats in which procaine HCI caused increased feeding. The brain, therefore, is directly sensitive to glucoprivation in the control of feeding, and glucoprivation alone is sufficient to mobilize feeding behavior. The specific site of sensitivity to glucoprivation and the mode of action of the glucoprivic system in the brain are unknown.
neurology of feeding; glucoprivation; glucoprivic system; cerebral mechanisms of behavior; ingestive behavior; core temperature into the study of the physiology of food intake, Smith and Epstein (45) clarified the nature of the change in glucose metabolism that is sufficient to initiate feeding behavior. This substance is a glucose analogue that competitively inhibits the intracellular metabolism of glucose (9, 22, 51, 53) in all tissues studied and especially in the brain. The elicitation of food intake by its peripheral administration showed that decreased intracellular glucose utilization or glucoprivation was the initiating metabolic event that leads to food intake when glucose metabolism is impaired. Smith and Epstein concluded that the control of food intake by glucoprivation employs detectors for the glucoprivic event that are within the brain itself. Their argument relied on the well-known efficacy of exogenous insulin for the production of food intake (7, 8, 28, 39, 45, 49) Behavioral observations and food and water measurements were made over a 4-h period, at the same time of day, on each injection day and on the baseline day. A single base-line day was followed by 3 injection days separated by 2 rest days between each injection day. On an injection day rats were hooked up to the same remote injection apparatus used in experiment I and given lo-15 min to accommodate to the apparatus. The heparin solution in the jugular catheter was flushed into the rat in order to fill the catheter with test solution.
On the 1st injection day the rats were tested with 4 small-volume injections at l-h intervals. Volumes of 7, 7, 14, and 25 ~1 of 2-DG solution were infused intravenously, allowing 1 h for observation after each injection.
The respective doses were 2.9, 2.9, 5.8, and 10.4 mg infused at the rate of 7 pl-min.
This served to mimic the ICV injections given in the first experiment. On the 2nd injection day the rats were infused over a 3-min period with 500 ~1 of isotonic saline. On the 3rd injection day the rats were given a high dose of Z-DG (equivalent to 500 mg/kg in las as described in experiment 1. They were tested with 2-DG 475 ~1 of solution)
to verify the adequacy of the preparation. and glucose, using the same injection procedure as described At the completion of the study the rats were sacrificed for a for the ICV injections. There were 3 injection days, 3-4 days apart. On the 1st injection day half the rats were given isotonic saline solution subcutaneously in a volume equal to the volume of 2-DG solution (dose = 25 mg/kg). On the 2nd injection day the solutions were reversed. On the last injection day the six rats were given the high 500 rug/kg dose of 2-DG to verify their responsiveness to glucoprivation. 38) were then tested for feeding on separate injection days with ICV Z-DG in the same manner as the rats in experiment 1. At the conclusion of the study the rats were sacrificed by an overdose of sodium pentobarbital immediately after a lo-p1 ICV injection of methyl green dye (25 S;) was made through the cannula.
The presence of the dye in the ventricular system confirmed the location of the cannula tip in the lateral ventricle. Core temperuture eJ'ects of 2-DG. When given systemically 2-DG is an antimetabolite that transiently lowers metabolic rate (36, 53). The decreased metabolism should result in Results: Experiment I decreased heat production and can be expected to lower core Intracerebroventricular injections. Table  1 compares for each temperature.
The hypothermia may underlie the increased rat its food intake during the base-line day with its intake feeding.
Groups min. The motor activity induced by 2-DC was followed by varying severities and durations of ataxia and stupor. These symptoms did not correlate with the onset of feeding. In 11 tests with 2-DG eating began before signs of stupor or ataxia were observed. The animals had either moved about the cage or had just moved from a normal stationary stance to a pellet before beginning to eat. In six cases the eating began and/or continued while the rat showed signs of stupor and ataxia. In two cases the rats began eating after having gone through a phase of slight stupor and ataxia. In the last case, the rat ate without exhibiting stupor or ataxia.
Histological examination confirmed the location of the cannula tips within the lateral cerebral ventricle in all animals (Fig. 1) . In the vicinity of the cannula tip, there usually was a slight hydrocephalus and localized parenchymal destruction.
Peripherally administered 2-DG. When given intravenously the low-dose equivalent to the effective ICV dose did not increase feeding in rats. However, all three rats ate at higher intravenous doses of approximately 200 mg 2-DC (equivalent to 500 mg/kg). The average increase in feeding above base line was 3.8 g. There was no significant change in feeding following the isotonic saline injection (Table 2) . Postmortem examination verified the proper placement and patency of the catheters.
The six rats given the low dose of 2-DC subcutaneously (25 mg/kg) showed no significant change in feeding. After the 500-mg/kg dose of 2-DC, however, each rat increased its feeding above the base line. The average increase in feeding was 2.5 g (P < 0.01, t test for correlated means) ( Table   3 ).
Core temperature efects of 2-DG. As shown in Fig. 2, 2 -DC produced a dose-dependent drop in core temperature after peripheral injection. With the maximum dose (750 mg/kg) core temperature fell 3°C. At one intermediate dose of 2-DG there was a 1.5% drop, and with the lowest 2-DC dose and the glucose dose of 750 mg/kg there was very little change. Core temperature began falling between 10 and 20 min after the intraperitoneal injection. It fell at a maximal rate at about 30 min. Core temperature remained depressed for more than 3 h at the maximal 2-DG dose. This may be an indicator of the duration of glucoprivation.
In the rats prepared with ICV cannulas base-line core temperatures were stable but elevated compared to normal rats. Figure 3 shows that ICV 2-DG, glucose and urea produced no consistent effects on core temperature. There were no precipitous temperature drops as seen with the intraperitoneal injections. Two rats had an immediate 1°C fall in core temperature; however, one temperature drop followed a 2-DG injection and the other followed a glucose injection. Regardless of the substance tested, ICV injections produced no consistent changes in core temperature. 37 , and 38 were tested with ICV 2-DG injections for feeding to confirm their identity with the animals studied in experiment I. Their feeding increased by an average of 2.2 g (range, 1.6-2.6 g).
Discussion
Intracerebroventricular injections.
This experiment shows clearly that 2-DG injected into the lateral cerebral ventricles will increase feeding, The amount eaten is equivalent to a large, single, spontaneous meal for the rat (26) and it occurs with a short latency. The same absolute increase in feeding observed by Smith and Epstein (45) with peripherally administered 2-DG was observed here with direct central application, but at a dose (2.9 or 5.8 mg per rat) that was between 1/50th and l/lOOth of their peripheral dose (750 mg/kg body wt) and with one-half the latency. The increased feeding appears, then, as an extra, spontaneous meal shortly after the 2-DG injection. This contrasts with the increased feeding caused by exogenous insulin administration. Insulin-induced feeding occurs with a longer latency (8, 45 ) and seems to be due to an increase in the size of a meal that would have occurred had the insulin injection not been made (8) . so that the doses of 2-DG per rat were from 0.001 to 0.150 mg. Injections were made over a period of 5-10 s by hand with a remote microsyringe in a manner similar to that described for experiment 1. Generally, feeding was observed for a l-h period after an injection. In many cases multiple injections of 2-DG (multiplying the above milligram doses) were tried if feeding did not occur with a single injection.
Five of the Sprague-Dawley males were also tested with procaine HCl (50 mg/ml) after overnight food deprivation to inhibit feeding and thereby verify the location of the cannulas within the feeding area of the LH. The overnight food deprivation began in the late afternoon.
On the following day, the rats were given wet mash (1 part by weight Purina rat chow powder to 1.5 parts water) after being prepared for remote injection. The procaine injections began when a rat had begun to eat. They were given 0.5-to 2-~1 bilateral injections. The duration of the inhibition of feeding was measured and a second injection given once the rat resumed eating.
In some cases three injections were given. ALH AND PO RATS. Two groups of rats were prepared with bilateral cannulas aimed for either the LH at the level of the anterior hypothalamus or for the preoptic area. There were seven Sprague-Dawley rats (five males and two females) weighing between 3 18 and 403 g prepared with PO cannulas and three Sprague-Dawley males weighing between 363 and 390 g prepared with ALH cannulas. The respective coordinates for the PO cannulas and the ALH cannulas were: A 8.5-9.2 mm, L 1.1-1.5 mm, D 7.1-7.5 mm, and A 7.8-8.1 mm, L 1.4 mm, D 7.4 mm. Both groups of rats were tested with 2-DG solutions of the following concentration (wt/vol) : 500, 5,000, 7,500, and 15,000 mg/ 100 ml (0.030-0.915 M). v o 1 umes of l-3 ~1 were infused bilaterally over a period of 5-10 s with a Harvard Apparatus infusion pump. The 2-DG doses were 0.010-0.90 mg per rat. Several rats were tested with more than one infusion.
Feeding and drinking behavior was observed for 1 h after an infusion. At the end of the studies the rats were sacrificed and the brains were removed for gross anatomical diagnosis of the cannula-tip locations. 2-DG andprocaine tests in VMH area. Three naive, SpragueDawley female rats weighing between 242-293 g were prepared with bilateral cannulas aimed at the VMH. The coordinates used were: A 6.0 mm, L 0.6 mm, and D 8.3 mm. After a recovery period of several days the rats were placed on a feeding schedule in which wet mash (described above) was offered during the afternoon along with the pellets. Each rat was studied with bilateral injections of procaineHCl (50 mg/ m isotonic saline), two doses of 2DG (75 1 mg/ml isotonic saline and 200 mg/ml isotonic saline), and a base-line (no injection) test. At the beginning of each session, the rat was removed from its cage and an injector was inserted into each cannula. Fresh wet mash was placed in the cage and the rat was replaced and given 10-l 5 min to accommodate to the presence of the wet mash and the injection apparatus. The average duration of inhibition of feeding was 8.0 min (range, 0.5-20 min) for 13 injections in the five rats. See Fig. 4 for location of injection sites within the hypothalamus.
ALH and PO rats. There was one instance of feeding in the PO group and four examples of drinking. Feeding in this rat, however, could not be replicated.
In the ALH preparation three rats ate small amounts of food (less than 1.0 g) with latencies of 4.5 to greater than 30 min. In two rats feeding could not be replicated.
The third rat ate twice but less than 0.5 g each time. Each of these rats also drank at least once. Drinking, when it occurred, ranged from 1 min 20 s to 14 min in latency and never exceeded 1.5 ml of water intake. See Fig. 4 for locations of injection sites within the ALH and PO.
VMH rats. Figure 5 presents data from this experiment.
On base-line days the rats ate an average of 2.7 g (range, 0.9-3.7 g) wet mash. Each rat was tested twice with proCaine-HCl, once with 4 ~1 of 75 mg/ml2-DG and twice with 4 ~1 of 200 mg/ml 2-DG. The 2-DG infusions at concentrations of either 75 mg/ml or 200 mg/ml produced no increase in feeding. The average 24-h intake subsequent to the 2-DG injections (17.6 g) was not different from the average 
